InvestorsHub Logo
Followers 3
Posts 582
Boards Moderated 0
Alias Born 01/19/2012

Re: None

Sunday, 09/16/2018 7:08:20 PM

Sunday, September 16, 2018 7:08:20 PM

Post# of 7763
The Week Ahead In Biotech (Sept. 16-22): Geron Corporation (NASDAQ: GERN) and Johnson & Johnson (NYSE: JNJ) are scheduled to release primary analysis of data from the Phase 2 IMbark study for Imetelstat to treat myelofibrosis
https://finance.yahoo.com/news/week-ahead-biotech-sept-16-182216424.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GERN News